Pathogenesis of inner environment changes in acute muscular compartment syndrome

Česká verzia

Authors: Angela Molčányiová ¹; Theodoz Molčányi ²
Authors place of work: Laboratóriá Labmed, a. s., Košice, Slovenská republika, výkonný riaditeľ Ing. Vladimír Nestor ¹; Klinika úrazovej chirurgie LF UPJŠ a UN L. Pasteura Košice, Slovenská republika, prednosta prof. MUDr. Miroslav Kitka, PhD. ²
Published in the journal: Vnitř Lék 2014; 60(3): 216-224
Category: Reviews

Summary

Acute compartment syndrome results from a pressure increase within an anatomically defined space delineated by a non-elastic surrounding. Every muscle group, encased by fascia/bone, presents a compartment with a potential to develop increased pressure under certain conditions. Increase in pressure within the compartment causes a decrease in perfusion pressure, leading to ischemia and pathological utilisation of energy substrates on the cellular level. Initially, the malfunction of cellular metabolism is functional and reversible. Later progress of these changes leads into irreversible myonecrosis. Restitution of blood supply reverses the local ischemia, however, the following reperfusion syndrome associated with oxidative stress, leads to further pathological sequelae. Re-established blood circulation carries the end-products of myonecrosis and activated immunocompetent cells from the site of lesion into the whole body. Furthermore, locally activated endothelium becomes a significant source of systemic inflammatory mediators. Pro-inflammatory conditions induce the response of anti-inflammatory regulatory mechanisms and their mutual interaction determines both local and systemic outcome of the disease.

Key words:
acute muscular compartment syndrome – muscle ischemia – rhabdomyolysis – reperfusion syndrome

Zdroje

1. Aird WC. The role of endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101(10): 3765–3777.

2. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365 (9453): 63–78.

3. Barnard M. Rhabdomyolysis. Update in Anaesthesia 2012; 28: 130–132.

4. Bauer C, Walcher F, Holanda M et al. Antioxidative resuscitation solution prevents leukocyte adhesion in the liver after hemorrhagic shock. J Trauma 1999; 46(5): 886–893.

5. Better OS, Stein JH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 1990; 322(12): 825–829.

6. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 2002; 10(6):620–630.

7. Bocca G, van Moorselaar JA, Feitz WFJ et al. Compartment syndrome, rhabdomyolysis and risk of acute renal failure as complications of the lithotomy position. J Nephrol 2002; 15(2): 183–185.

8. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009; 361(1): 62–72.

9. Brumback RA, Feeback DL, Leech RW. Rhabdomyolysis in childhood: A primer on normal muscle function and selected metabolic myopathies characterized by disordered energy production. Pediatr Clin North Am 1992; 39(4): 821–858.

10. Criddle LM. Rhabdomyolysis. Pathophysiology, recognition, and management. Crit Care Nurse 2003; 23(6): 14–22, 24–26, 28.

11. Daher Ede F, da Silva jr. GB, Brunetta DM et al. Rhabdomyolysis and acute renal failure after strenuous exercise and alcohol abuse: case report and literature review. Sao Paolo Med J 2005; 123: 33–37.

12. David WS. Myoglobinuria. Neurol Clin 2000; 18(1): 215–243.

13. De Lonlay-Debeney P, Edery P, Cormier-Daire V et al. Respiratory chain deficiency presenting as recurrent myoglobinuria in childhood. Neuropediatrics 1999; 30(1): 42–44.

14. Demling RH, LaLonde C, Knox J et al. Fluid resuscitation with deferoxamine prevents systemic burn-induced oxidant injury. J Trauma 1991; 31(4): 538–543.

15. Demling RH, LaLonde C. Early postburn lipid peroxidation: effect of ibuprofen and allopurinol. Surgery 1990; 107(1): 85–93.

16. Efstratiadis G, Voulgaridou A, Nikiforou D et al. Rhabdomyolysis updated. Hippokratia 2007; 11(3): 129–137.

17. Friedl HP, Till GO, Ryan US et al. Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J 1989; 3(13): 2512–2518.

18. Haas CE, Magram Y, Mishra A. Rhabdomyolysis and Acute Renal Failure Following an Ethanol and Diphenhydramine Overdose. Ann Pharmacother 2003; 37(4): 538–542.

19. Hack CE. Tissue factor pathway of coagulation in sepsis. Crit Care Med 2000; 28( Suppl 9): S25-S30.

20. Henneke P, Golenbock DT. Innate immune recognition of lipopolysaccharide by endothelial cells. Crit Care Med 2002; 30(Suppl 5): S207-S213.

21. Holt S, Moore K. Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin. Exp Nephrol 2000; 8(2): 72–76.

22. Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med 2001; 27(5): 803–811.

23. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians. Crit Care 2005; 9(2): 158–169.

24. Hunter JD, Gregg K, Damani Z. Rhabdomyolysis. Continuing Education in Anaesthesia, Critical Care & Pain 2006; 6(4): 141–143.

25. Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med 2009; 67(9): 272–283.

26. Knochel JP. Rhabdomyolysis and myoglobinuria. Ann Rev Med 1982; 33: 435–443.

27. Kroužecký A, Matějovič M, Rokyta jr. R et al. Rabdomyolýza – mechanismy vzniku, příčiny, důsledky a léčba. Vnitr Lek 2003; 49(8): 668–672.

28. Kumar P. Compartment syndrome: pathophysiology. Burns 2005; 31(1): 120.

29. Lane R, Phillips M. Rhabdomyolysis. BMJ 2003; 327 (7407): 115–116. Erratum in BMJ. 2003; 327(7413):500.

30. Lappalainen H, Tiula E, Uotila L et al. Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Crit Care Med 2002; 30(10): 2212–2215.

31. Lee CC, Marill KA, Carter WA et al. A current concept of trauma-induced multiorgan failure. Ann Emerg Med 2001; 38(2): 170–176.

32. Lindsay TF, Liauw S, Romaschin AD et al. The effect of ischemia/reperfusion on adenine nucleotide metabolism and xanthine oxidase production in skeletal muscle. J Vasc Surg 1990; 12(1): 8–15.

33. Line RL, Rust GS. Acute exertional rhabdomyolysis. Am Fam Physician 1995; 52(2): 502–506.

34. Lopez JR, Linares N, Cordovez G et al. Elevated myoplasmic calcium in exercise-induced equine rhabdomyolysis. Pflugers Arch 1995; 430(2): 293–295.

35. Lopez JR, Rojas B, Gonzalez MA et al. Myoplasmic Ca2+concentration during exertional rhabdomyolysis. Lancet 1995; 345: 424–425.

36. Loun B, Astles R, Copeland KR et al. Adaptation of a quantitative immunoassay for urine myoglobin. Predictor in detecting renal dysfunction. Am J Clin Pathol 1996; 105(4): 479–486.

37. Malinoski DJ, Slater MS, Mullins RJ. Crush injury and rhabdomyolysis. Crit Care Clin 2004; 20(1): 171–192.

38. Minigh JL, Valentovic MA. Characterization of myoglobin toxicity in renal cortical slices from Fischer 344 rats. Toxicology 2003; 184(2–3): 113–123.

39. Moghtader J, Brady WJ, Bonadio W. Exertional rhabdomyolysis in an adolescent athlete. Pediatr Emerg Care 1997; 13(6): 382–385.

40. Molčányi T, Živčák J, Molčányiová A. Prejavy kompartment syndrómu. ManaCon: Prešov 2010. ISBN 978–80–89040–37–7.

41. Mubarak SJ, Hargens AR. Acute compartment syndromes. Surg Clin North Am 1983; 63(3): 539–565.

42. Mydlík M, Derzsiová K, Bohuš B. Zmeny vo funkčnom renálnom náleze po maratónskom behu, po 100-kilometrovom behu a po 24-hodinovom dlhotrvajúcom behu. Vnitr Lek 2009; 55(Suppl1): S103-S107.

43. Oestern HJ. Kompartment syndrom. Definition, Ätiologie, Pathophysiology. Unfallchirurg 1991; 94(5): 210–215.

44. Opal SM, Esmon CT. Bench-to-bedside review: functional relationships between coagulation and innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003; 7(1): 23–38.

45. Poels PJE, Gabreels FJM. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 1993; 95: 175–192.

46. Prendergast BD, George CF. Drug induced rhabdomyolysis – mechanisms and management. Postgrad Med J 1993; 69(811): 333–336.

47. Radovanović MR, Milovanović DR, Ignjatović-Ristić D et al. Heroin addict with gangrene of the extremities, rhabdomyolysis and severe hyperkalemia. Vojnosanit Pregl 2012; 69(10): 908–912.

48. Rubin B, Liauw S, Tittley J et al. Prolonged adenine nucleotide resynthesis and reperfusion injury in post-ischemic skeletal muscle. Am J Physiol 1992; 262 (5 Pt 2): H1538-H1547.

49. Russell T. Acute renal failure related to rhabdomyolysis: pathophysiology, diagnosis, and collaborative management. Nephrol Nurs J 2005; 32(4): 409–417.

50. Russell TA. Acute renal failure related to rhabdomyolysis: pathophysiology, diagnosis, and collaborative management. Nephrol Nurs J 2000; 27(6): 576–577.

51. Slater MS, Mullins RJ. Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review. J Am Coll Surg 1998; 186(6): 693–716.

52. Steinau HU. Major Limb Replantation and Postischemia Syndrome. Investigation of Acute Ischemia-induced Myopathy and Reperfusion Injury. New York: Springer Verlag 1988: 9–22, 23, 26, 33. ISBN 978–3-662–02482–9.

53. Sugino K, Dohi K, Yamada K et al. The role of lipid peroxidation in endotoxin-induced hepatic damage and protective effects of antioxidants. Surgery 1987; 101(6): 746–752.

54. Tan W, Herzlich BC, Funaro et al. Rhabdomyolysis and myoglobinuric acute renal failure associated with classic heat stroke. South Med J 1995; 88(10): 1065–1068.

55. Vanholder R, Sever M, Erek E et al. Acute renal failure related to the crush syndrome: towards an era of seismo-nephrology? Nephrol Dial Transplant 2000; 15(10): 1517–1521.

56. Vanholder R, Sever M, Erek E et al. Rhabdomyolysis. J Am Soc Nephrol 2000; 11(8): 1553–1561.

57. Visweswaran P, Guntupalli J. Rhabdomyolysis. Crit Care Clin 1999; 15(2): 415–428.

58. Walter LA, Catenacci MH. Rhabdomyolysis. Hospital physician 2008; 44(1): 25–31.

59. Ward M. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 1988; 148(7): 1553–1557.

60. Wrogemann K, Pena SD. Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases. Lancet 1976; (7961): 672–674.

61. Zager RA. Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria. Kidney Int 1996; 49(3): 741–751.

62. Závada J. Syndrom multiorgánové dysfunkce. Praha: Grada Publishing 2001. ISBN 80–7169–781–8.

63. Zimmerman GA, McIntyre TM, Prescott SM et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 2002; 30(Suppl 5): S294-S301.